SunLink Health(SSY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SSY SunLink Health

Post-Mkt 12-11 16:51:00 EST

1.12

+0.00

0.00%

High1.12	Low1.12	Vol0.00
Open1.12	D1 Closing1.12	Amplitude0.00%
Mkt Cap7.85M	Tradable Cap5.20M	Total Shares7.04M
T/O0.00	T/O Rate0.00%	Tradable Shares4.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SSY","market":"US","secType":"STK","nameCN":"SunLink Health","latestPrice":1.115,"timestamp":1765486800000,"preClose":1.115,"halted":0,"volume":0,"delay":0,"floatShares":4663170,"shares":7040603,"eps":0.245019,"marketStatus":"Post-Mkt","change":0,"latestTime":"12-11 16:51:00 EST","open":1.115,"high":1.115,"low":1.115,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.245019,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.115,"volumeRatio":0},"requestUrl":"/m/hq/s/SSY","defaultTab":"news","newsList":[{"id":"2590394131","title":"SSY Group Gets China Nod for Registration of Two Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2590394131","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590394131?lang=en_us&edition=fundamental","pubTime":"2025-12-09 13:12","pubTimestamp":1765257172,"startTime":"0","endTime":"0","summary":"SSY Group  obtained production and registration approval for two products from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.The approvals are for Levofloxacin Eye Drops used to treat blepharitis, meibomianitis, dacryocystitis, and conjunctivitis among other illnesses, and Compound Sodium Picosulfate Granules used in bowel cleansing preparation before colonoscopy, X-ray, and surgery.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2460026573.USD","SSY","BK1191","BK4185","02005"],"gpt_icon":0},{"id":"2589289361","title":"Is NMPA’s Wave Of Drug Approvals Altering The Investment Case For SSY Group (SEHK:2005)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2589289361","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589289361?lang=en_us&edition=fundamental","pubTime":"2025-12-05 14:15","pubTimestamp":1764915301,"startTime":"0","endTime":"0","summary":"In late November 2025, SSY Group reported a series of approvals from China’s National Medical Products Administration for new and existing drugs, including treatments for overactive bladder, respiratory diseases, liver-related cholestasis and vitamin A supplementation.\nThese clustered approvals, many classified as passing China’s consistency evaluation, underline SSY Group’s push to broaden its portfolio of higher-quality, regulated pharmaceutical products in its home market.\nWe’ll examine...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/is-nmpas-wave-of-drug-approvals-altering-the-investment-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/is-nmpas-wave-of-drug-approvals-altering-the-investment-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4185","BK1191","SSY","02005","LU2460026573.USD"],"gpt_icon":0},{"id":"2588000809","title":"SSY Group Gets Bulk Drug Approvals in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2588000809","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588000809?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:36","pubTimestamp":1764840995,"startTime":"0","endTime":"0","summary":"SSY Group  obtained registration approvals for Bilastine and Sodium Picosulfate from China's National Medical Products Administration to become bulk drugs for preparations on the market, a Thursday Hong Kong bourse filing said.Bilastine is mainly used for the symptomatic treatment of urticaria, while sodium picosulfate is used to cleanse the colon before surgical examination.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SSY","02005","LU2460026573.USD","BK4185","BK1191"],"gpt_icon":0},{"id":"2588704897","title":"Assessing SSY Group (SEHK:2005) Valuation Following New Drug Approvals and Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2588704897","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588704897?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:16","pubTimestamp":1764609400,"startTime":"0","endTime":"0","summary":"SSY Group (SEHK:2005) just secured multiple new drug production and registration approvals from China’s National Medical Products Administration, spanning both specialty treatments and bulk drugs. This signals tangible advancement in the company’s pharmaceutical pipeline.\nSee our latest analysis for SSY Group.\nAfter a challenging start to the year, SSY Group’s share price has shown renewed momentum, achieving a 9.5% return over the past 90 days and rising 1.6% just yesterday as investors...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/assessing-ssy-group-sehk2005-valuation-following-new-drug-ap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/assessing-ssy-group-sehk2005-valuation-following-new-drug-ap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","LU2460026573.USD","BK4185","DCF","PRGS","LU2065732104.USD","BK4097","02005","SSY"],"gpt_icon":0},{"id":"2586203811","title":"SSY Group Wins China Production, Registration Approval for Overactive-Bladder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2586203811","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586203811?lang=en_us&edition=fundamental","pubTime":"2025-11-28 13:08","pubTimestamp":1764306531,"startTime":"0","endTime":"0","summary":"SSY Group  said it has received drug production and registration approval from China's National Medical Products Administration for its 4mg Tolterodine Tartrate sustained-release capsules, according to a Friday Hong Kong bourse filing.The product, classified as a type 4 chemical drug and deemed to have passed consistency evaluation, is used for managing overactive bladder, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2460026573.USD","02005","SSY","BK1191","BK4185"],"gpt_icon":0},{"id":"2586081322","title":"SSY Group Secures Approval for New Drug Production in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2586081322","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586081322?lang=en_us&edition=fundamental","pubTime":"2025-11-28 12:08","pubTimestamp":1764302929,"startTime":"0","endTime":"0","summary":"An update from SSY Group ( ($HK:2005) ) is now available. SSY Group Limited has announced that it received approval from the National Medical Produ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-group-secures-approval-for-new-drug-production-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-group-secures-approval-for-new-drug-production-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","SSY"],"gpt_icon":0},{"id":"2586215655","title":"SSY Group’s Vitamin A Palmitate Gains Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2586215655","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586215655?lang=en_us&edition=fundamental","pubTime":"2025-11-27 12:09","pubTimestamp":1764216555,"startTime":"0","endTime":"0","summary":"SSY Group ( ($HK:2005) ) has issued an announcement. SSY Group Limited announced that its Vitamin A Palmitate has received approval from the Nation...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-groups-vitamin-a-palmitate-gains-approval-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-groups-vitamin-a-palmitate-gains-approval-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSY","BK4185"],"gpt_icon":0},{"id":"2586287589","title":"What SSY Group (SEHK:2005)'s New Respiratory and Liver Drug Approvals Mean For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287589","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586287589?lang=en_us&edition=fundamental","pubTime":"2025-11-26 09:22","pubTimestamp":1764120147,"startTime":"0","endTime":"0","summary":"Earlier this week, SSY Group Limited received approval from China's National Medical Products Administration for several new drugs targeting respiratory and liver conditions, including Aminophylline Tablets, Procaterol Hydrochloride Inhalation Solution, and Ademetionine 1,4-Butanedisulfonate for Injection. \nThis milestone not only broadens SSY Group’s portfolio but also strengthens its presence in key therapeutic areas with significant healthcare demand.\nWe’ll explore how these regulatory...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/what-ssy-group-sehk2005s-new-respiratory-and-liver-drug-appr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/what-ssy-group-sehk2005s-new-respiratory-and-liver-drug-appr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2460026573.USD","SSY","BK1191","02005","BK4185"],"gpt_icon":0},{"id":"2585464734","title":"SSY Group Gets China Nod for Registration of Asthma, Bronchitis Drug for Bulk Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2585464734","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585464734?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:50","pubTimestamp":1763988646,"startTime":"0","endTime":"0","summary":"SSY Group  obtained production and registration approval for the Aminophylline Tablets from China's National Medical Products Administration to become a bulk drug for preparations on the market, a Monday Hong Kong bourse filing said.The move came as the drug is regarded as passing the regulator's consistency evaluation.The drug is mainly used to relieve wheezing symptoms in bronchial asthma, wheezing bronchitis, and obstructive emphysema, and to treat asthma caused by cardiogenic pulmonary edema.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","SSY","02005","BK4185","LU2460026573.USD"],"gpt_icon":0},{"id":"2585671452","title":"SSY Group Secures Key Drug Approvals in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2585671452","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585671452?lang=en_us&edition=fundamental","pubTime":"2025-11-24 16:38","pubTimestamp":1763973536,"startTime":"0","endTime":"0","summary":"SSY Group ( ($HK:2005) ) has shared an update. SSY Group Limited has received approval from the National Medical Products Administration of China f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-group-secures-key-drug-approvals-in-china-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-group-secures-key-drug-approvals-in-china-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","SSY"],"gpt_icon":0},{"id":"2583258315","title":"SSY Group Gains Approval for Indobufen Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2583258315","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583258315?lang=en_us&edition=fundamental","pubTime":"2025-11-14 12:39","pubTimestamp":1763095159,"startTime":"0","endTime":"0","summary":"SSY Group ( ($HK:2005) ) has provided an announcement. SSY Group Limited has received approval from the National Medical Products Administration of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-group-gains-approval-for-indobufen-tablets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-group-gains-approval-for-indobufen-tablets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSY","BK4185"],"gpt_icon":0},{"id":"2581962840","title":"How Investors Are Reacting To SSY Group (SEHK:2005) Winning Approval For Its Vitamin B6 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2581962840","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581962840?lang=en_us&edition=fundamental","pubTime":"2025-11-06 15:37","pubTimestamp":1762414634,"startTime":"0","endTime":"0","summary":"SSY Group Limited recently announced that its Vitamin B6 Injection received approval from the National Medical Products Administration of China for the Consistency Evaluation of the Quality and Efficacy of Generic Drugs.\nThis regulatory milestone broadens SSY Group’s product range and could improve treatment access for individuals affected by vitamin B6 deficiency in China.\nWe'll explore how this regulatory approval in China could influence SSY Group’s investment narrative, particularly...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/how-investors-are-reacting-to-ssy-group-sehk2005-winning-app","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2005/ssy-group-shares/news/how-investors-are-reacting-to-ssy-group-sehk2005-winning-app","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02005","ISBC","SSY","BK4185","BK1191","BK4211","LU2460026573.USD"],"gpt_icon":0},{"id":"2581703728","title":"Halliburton Wins Integrated Drilling Services Contract for Offshore Nigeria Gas Field","url":"https://stock-news.laohu8.com/highlight/detail?id=2581703728","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581703728?lang=en_us&edition=fundamental","pubTime":"2025-11-06 03:16","pubTimestamp":1762370184,"startTime":"0","endTime":"0","summary":"Halliburton Company has been awarded an Integrated Drilling Services contract by Shell Nigeria Exploration and Production Company , in collaboration with Sunlink Energies, for work in OML 144 offshore Nigeria. Under the contract, Halliburton will support the HI gas field development to supply feed gas to the Nigeria LNG Train 7 facility. The company will provide integrated drilling and completion services, deploying advanced technologies and automation to enhance drilling precision, efficiency, and safety. Halliburton's Project Management team will oversee execution and integration of services for the project.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Halliburton Company published the original content used to generate this news br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDLbzW1l6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256331488.USD","BK4179","SSY","BK4585","BK4185","BK4588","HAL"],"gpt_icon":0},{"id":"2580521142","title":"Brownie's Marine Group Sets New CEO Compensation Package with Salary, Bonus, and Equity Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=2580521142","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580521142?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:31","pubTimestamp":1762180279,"startTime":"0","endTime":"0","summary":"Brownie's Marine Group Inc. has approved a revised compensation package for Chief Executive Officer Robert Carmichael. Effective November 1, 2025, Carmichael's annual base salary will be set at $246,000. He will be eligible for an annual bonus of $98,400, based on specific performance metrics. Additionally, Carmichael is set to receive performance-based restricted stock units valued at $150,000 and cashless stock options valued at $350,000, with terms to be determined by the board under the company's 2021 Equity Compensation Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brownie's Marine Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval sys","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL1sslhp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSY","BWMG","BK4185","BK4190"],"gpt_icon":0},{"id":"2580426225","title":"SSY Group Gains Approval for Three New Bulk Drugs in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2580426225","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580426225?lang=en_us&edition=fundamental","pubTime":"2025-11-03 16:38","pubTimestamp":1762159081,"startTime":"0","endTime":"0","summary":"SSY Group ( ($HK:2005) ) has issued an update. SSY Group Limited has announced the approval of three bulk drugs—Fenofibrate, Choline Fenofibrate, a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-group-gains-approval-for-three-new-bulk-drugs-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-group-gains-approval-for-three-new-bulk-drugs-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSY","BK4185"],"gpt_icon":0},{"id":"2580230330","title":"SSY Group’s Vitamin B6 Injection Gains Regulatory Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2580230330","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580230330?lang=en_us&edition=fundamental","pubTime":"2025-11-03 08:09","pubTimestamp":1762128588,"startTime":"0","endTime":"0","summary":"SSY Group ( ($HK:2005) ) has provided an announcement. SSY Group Limited has announced that its Vitamin B6 Injection has received approval from the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-groups-vitamin-b6-injection-gains-regulatory-approval-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-groups-vitamin-b6-injection-gains-regulatory-approval-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSY","BK4185"],"gpt_icon":0},{"id":"2579177472","title":"Regional Health Properties Issues Correction to Merger Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2579177472","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579177472?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:31","pubTimestamp":1761856289,"startTime":"0","endTime":"0","summary":"Regional Health Properties Inc. has issued an amendment to its current report, providing unaudited pro forma condensed combined financial statements to reflect the estimated effects of its upcoming merger with SunLink Health Systems, Inc. The amendment includes updated financial information as of June 30, 2025, and details related to the merger agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regional Health Properties Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL7mx4r4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SSY","BK4185","RHEP"],"gpt_icon":0},{"id":"2578955286","title":"SSY Group Q1-Q3 Profit Slides 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578955286","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578955286?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:41","pubTimestamp":1761651691,"startTime":"0","endTime":"0","summary":"SSY Group  recorded an attributable profit of HK$399 million in the first nine months, down 57% from a year prior, a Tuesday Hong Kong bourse filing said.Turnover for the three quarters fell 32% to roughly HK$3.1 billion, mainly due to a drop in the sales volume of intravenous infusion solution and turnover from ampoule injections.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02005","LU2460026573.USD","BK4185","SSY","BK1191"],"gpt_icon":0},{"id":"2578387899","title":"SSY Group Reports Significant Decline in Nine-Month Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2578387899","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578387899?lang=en_us&edition=fundamental","pubTime":"2025-10-28 16:38","pubTimestamp":1761640724,"startTime":"0","endTime":"0","summary":"An update from SSY Group ( ($HK:2005) ) is now available. SSY Group Limited reported a significant decline in its unaudited operating results for t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ssy-group-reports-significant-decline-in-nine-month-operating-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ssy-group-reports-significant-decline-in-nine-month-operating-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSY"],"gpt_icon":0},{"id":"2578983414","title":"SSY Group Wins Chinese Government Bid to Supply Medicines to Healthcare Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2578983414","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578983414?lang=en_us&edition=fundamental","pubTime":"2025-10-28 13:16","pubTimestamp":1761628569,"startTime":"0","endTime":"0","summary":"SSY Group  said it won a bid to supply 12 medicines to government-linked healthcare facilities in China, according to a Hong Kong bourse filing Tuesday.The company had submitted tenders for 14 medicines, of which it won 12, namely diprophylline injection, formoterol fumarate inhalation solution, fluvoxamine maleate tablets, lornoxicam for injection, epinephrine hydrochloride injection, bromhexine hydrochloride injection, multiple electrolyte injection, multiple electrolyte injection , nicorandil tablets, salbutamol sulfate injection, benidipine hydrochloride tablets, and sodium bicarbonate injection.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","LU0128526141.USD","LABU","MDCO","SSY","XLV","02005","BK4185","BK4581","BK4585","LU0029874061.USD","BK1191","XBI","HCSG","LU2460026573.USD","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sunlinkhealth.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.4867},{"period":"ytd","weight":0.267}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; four clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was founded in 1959 and is based in Atlanta, Georgia.","yearOnYearQuotes":[{"month":1,"riseRate":0.488889,"avgChangeRate":0.041009},{"month":2,"riseRate":0.488889,"avgChangeRate":0.017283},{"month":3,"riseRate":0.444444,"avgChangeRate":0.06387},{"month":4,"riseRate":0.456522,"avgChangeRate":0.021843},{"month":5,"riseRate":0.478261,"avgChangeRate":0.018563},{"month":6,"riseRate":0.608696,"avgChangeRate":0.050018},{"month":7,"riseRate":0.434783,"avgChangeRate":0.014033},{"month":8,"riseRate":0.543478,"avgChangeRate":0.027443},{"month":9,"riseRate":0.288889,"avgChangeRate":-0.035516},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.03265},{"month":11,"riseRate":0.511111,"avgChangeRate":0.040166},{"month":12,"riseRate":0.355556,"avgChangeRate":-0.04297}],"exchange":"AMEX","name":"SunLink Health","nameEN":"SunLink Health"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SunLink Health(SSY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SunLink Health(SSY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SunLink Health,SSY,SunLink Health股票,SunLink Health股票老虎,SunLink Health股票老虎国际,SunLink Health行情,SunLink Health股票行情,SunLink Health股价,SunLink Health股市,SunLink Health股票价格,SunLink Health股票交易,SunLink Health股票购买,SunLink Health股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SunLink Health(SSY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SunLink Health(SSY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction